Key result
Systematic screening detects wild-type ATTR-CA in ~1% of older men with ANOCA.
Why the study?
Cardiac amyloidosis can cause microvascular dysfunction and chest pain without obstructive CAD, and whether angina in older men represents an early manifestation of previously undiagnosed cardiac amyloidosis remained unknown.
Does a systematic screening protocol detect a significant prevalence of undiagnosed transthyretin cardiac amyloidosis in men aged ≥65 years presenting with chest pain and non-obstructive coronary findings?
Cohort (n=150)
Yes
Does a systematic screening protocol detect a significant prevalence of undiagnosed transthyretin cardiac amyloidosis in men aged ≥65 years presenting with chest pain and non-obstructive coronary findings?
Answers are grounded in this paper and cite their sources.
Routine systematic screening for transthyretin cardiac amyloidosis in older men with angina and non-obstructive coronary artery disease has a low diagnostic yield of 1.3%, indicating that additional clinical enrichment criteria are needed before screening.
Background Cardiac amyloidosis (CA) may cause microvascular dysfunction leading to chest pain, even in the absence of obstructive coronary artery disease (CAD). Whether angina in older men may represent an early clinical manifestation of previously undiagnosed CA remains unknown Methods In this prospective multicenter study, 150 men aged ≥65 years presenting with chest pain were recruited from three outpatient cardiology clinics in the Capital Region of Denmark. All par-ticipants had non-obstructive findings on coronary imaging by either cardiac computed to-mography angiography or myocardial perfusion imaging. A systematic screening protocol in-cluded clinical evaluation, electrocardiography, echocardiography, blood and urine tests for monoclonal proteins, and cardiac scintigraphy. ATTR-CA was defined by Perugini grade ≥2 myocardial uptake in the absence of monoclonal gammopathy. Results The median age was 72.6 years (IQR: 68.8–77.4). Most patients underwent perfusion imaging (63.0%) prior to inclusion. Median high-sensitive troponin T was 12.0 ng/L (IQR, 9.0–18.0), and median NT-proBNP was 173.9 ng/L (IQR 81.9–459.9). Heart failure was present in 24.0% and atrial fibrillation or flutter in 39.7% of patients. In total, two patients (1.3%; 95% CI 0.2- 4.%) were diagnosed with wild-type transthyretin CA with grade 3 cardiac uptake. One patient had manifest cardiomyopathy, and the second CA patient had normal cardiac biomarkers and echocardiography and was surveilled. Conclusions Among elderly men with suspected cardiac angina and non-obstructive coronary findings, the prevalence of undiagnosed ATTR-CA was low (1.3%). Additional enrichment criteria may be necessary to improve diagnostic yield, but this remains hypothesis-generating.
No takes yet. Share an insight, caveat, or question.
Noory et al. (2026) conducted a cohort in Angina with non-obstructive coronary artery findings (n=150). Systematic screening for cardiac amyloidosis (clinical evaluation, ECG, echocardiography, monoclonal protein testing, and cardiac scintigraphy) was evaluated on Diagnosis of transthyretin cardiac amyloidosis (ATTR-CA), defined by Perugini grade ≥2 myocardial uptake in the absence of monoclonal gammopathy (95% CI 0.2-4.%). Systematic screening for cardiac amyloidosis in elderly men with angina and non-obstructive coronary arteries detected wild-type ATTR-CA in 1.3%.
Synapse has enriched 10 related papers. Consider them for comparative context: